Drug safety analyses in a rheumatoid arthritis registry: application of different approaches regarding timing of exposure and confounder measurement
Crossref DOI link: https://doi.org/10.1186/s13075-017-1330-0
Published Online: 2017-06-13
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Solomon, Daniel H.
Shadick, Nancy A.
Weinblatt, Michael E.
Zak, Agnes
Frits, Michelle
Franklin, Jessica M.
Funding for this research was provided by:
Patient-Centered Outcomes Research Institute (US) (PCORI ME-1303-5602)